Putative Otobius megnini-associated clinical signs in horses in South Africa (2012-2018).

Otobius megnini has been associated with certain clinical conditions in horses in both California and Mexico. A number of cases similar to those described previously have been identified by the author in South Africa. This case report summarises these cases to demonstrate that the clinical condition occurs readily in South Africa and may be increasing in occurrence. The disease has minimal coverage in the literature making it more likely that a veterinarian, unfamiliar with the disease, will miss the diagnosis. The author would like to make veterinarians aware of this as a potential differential diagnosis. This study is a retrospective review of clinical data. Clinical records of patients with similar clinical signs and treatment were reviewed and grouped together as relevant cases for this case report. Ten cases of O. megnini associated neuromuscular dysfunction are reported, suggesting a link between the occurrence of the tick and the clinical condition. Clinical signs include third eyelid prolapse, localised muscle fasciculations, elevated heart rate and limb stamping. Serum chemistry changes commonly show increased aspartate aminotransferase and creatine kinase enzymes activities. The occurrence of the ticks within South Africa and the increasing number of cases presented demonstrate the need for more investigation into the pathophysiology of this condition.

Assessing Human Airway Epithelial Progenitor Cells for Cystic Fibrosis Cell Therapy.

Cystic fibrosis (CF) is caused by loss-of-function mutations in the CFTR (CF transmembrane regulator) gene. Pharmacologic therapies directed at CFTR have been developed but are not effective for mutations that result in little or no mRNA or protein expression. Cell therapy is a potential mutation-agnostic approach to treatment. One strategy is to harvest human bronchial epithelial cells (HBECs) for gene addition or genetic correction, followed by expansion and engraftment. This approach will require cells to grow extensively while retaining their ability to reconstitute CFTR activity. We hypothesized that conditionally reprogrammed cell (CRC) technology, namely growth in the presence of irradiated feeder cells and a Rho kinase inhibitor, would enable expansion while maintaining cell capacity to express functional CFTR. Our goal was to compare expression of the basal cell marker NGFR (nerve growth factor receptor) and three-dimensional bronchosphere colony-forming efficiency (CFE) in early- and later-passage HBECs grown using nonproprietary bronchial epithelial growth medium or the CRC method. Cell number and CFTR activity were determined in a competitive repopulation assay employing chimeric air-liquid interface cultures. HBECs expanded using the CRC method expressed the highest NGFR levels, had the greatest 3D colony-forming efficiency at later passage, generated greater cell numbers in chimeric cultures, and most effectively reconstituted CFTR activity. In our study, the HBEC air-liquid interface model, an informative testing platform proven vital for the development of other CF therapies, illustrated that cells grown by CRC technology or equivalent methods may be useful for cell therapy of CF.

Endoscopic recurrent laryngeal neuropathy grade prevalence in a sample of thoroughbred yearlings at public auction in South Africa (2013-2019).

Endoscopy of thoroughbred (TB) yearlings at public auctions is common in South Africa. Laryngeal function (LF) is a common concern of buyers of young TBs. Cancellation of sale because of LF abnormalities is a concern for both the vendor and the buyer, with recurrent laryngeal neuropathy (RLN) being a common cause of sale cancellation. The aim of this descriptive study was to determine the prevalence of RLN at South African premier TB yearling sales. This study was designed as a retrospective descriptive analysis of upper respiratory tract (URT) endoscopic examinations to determine RLN grade, performed at two premier TB yearling sales in South Africa. Results of buyer-requested endoscopic examination from 2013 to 2019 were included. Results from the yearling sales were analysed for prevalence of RLN grade (using Rakestraw's 4-point system) and compared to similar previously published studies. For analysis of effects of gender on RLN grading, horses were grouped and Fisher's exact test was used to determine if there was a relationship between gender and grade. For comparison of the effects of age on grade, and sales year on grade, a Kruskal-Wallis test was conducted. A value of p 0.05 was considered significant. A total of 858 horses were examined out of 4149 offered for sale; there were 57.58% colts and 42.42% fillies (mean age of 18.1 months). The annual percentage for grade 1 was 84.04% ± 9.98%, for grade 2: 14.49% ± 10.69%, for grade 3: 0.71% ± 0.57% and for grade 4: 0.76% ± 0.94%. There were no other significant findings. The exclusive nature of the sale and the increasing proclivity for pre-sale scoping may have skewed the results. This study shows that RLN grade incidences in TB yearlings at public auctions in South Africa are as follows: grade 1: 84.04%, grade 2: 14.49%, grade 3: 0.71% and grade 4: 0.76%. The results were similar to that of an adult population of horses examined in South Africa in a previous study.

Solar keratoma: An atypical case.

This case report shows that keratomas can occur in both hind feet of equine patients and should be considered as a diagnosis for long-standing, intermittent lameness localised to the hooves. A Thoroughbred racehorse presented with long-standing abscessation of the right hind hoof. Owing to the long-standing nature, the abscess draining tract was surgically explored. A focal mass was found within the solar horn. Histopathology revealed the mass to be a keratoma. A similar mass was removed from the left hind hoof a few months later after similar presenting signs. This case shows that keratomas can occur in more than one hoof within a short period and should be considered a differential diagnosis for long-standing lameness localised to the hoof.